Needham Investment Management’s LeMaitre Vascular LMAT Stock Holding History

Needham Investment Management’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.84M	Hold	40,000	–	–	0.12%	127
2026 Q1	$4.37M	Hold	40,000	–	–	0.22%	104
2025 Q4	$3.24M	Hold	40,000	–	–	0.21%	103
2025 Q3	$3.5M	Hold	40,000	–	–	0.24%	92
2025 Q2	$3.32M	Buy	40,000 +1,500	+4%	+$125K	0.26%	87
2025 Q1	$3.23M	Hold	38,500	–	–	0.3%	86
2024 Q4	$3.55M	Hold	38,500	–	–	0.27%	92
2024 Q3	$3.58M	Hold	38,500	–	–	0.27%	87
2024 Q2	$3.17M	Hold	38,500	–	–	0.26%	92
2024 Q1	$2.55M	Hold	38,500	–	–	0.24%	93
2023 Q4	$2.19M	Buy	38,500 +16,000	+71%	+$838K	0.28%	85
2023 Q3	$1.23M	Buy	22,500 +2,000	+10%	+$119K	0.21%	88
2023 Q2	$1.38M	Hold	20,500	–	–	0.23%	80
2023 Q1	$1.06M	Hold	20,500	–	–	0.18%	94
2022 Q4	$943K	Hold	20,500	–	–	0.17%	90
2022 Q3	$1.04M	Hold	20,500	–	–	0.2%	85
2022 Q2	$934K	Hold	20,500	–	–	0.17%	95
2022 Q1	$953K	Hold	20,500	–	–	0.14%	96
2021 Q4	$1.03M	Hold	20,500	–	–	0.13%	90
2021 Q3	$1.09M	Hold	20,500	–	–	0.15%	88
2021 Q2	$1.25M	Hold	20,500	–	–	0.18%	79
2021 Q1	$1M	Sell	20,500 -1,500	-7%	-$70.3K	0.14%	90
2020 Q4	$891K	Sell	22,000 -500	-2%	-$17.9K	0.15%	88
2020 Q3	$732K	Hold	22,500	–	–	0.15%	83
2020 Q2	$594K	Hold	22,500	–	–	0.13%	80
2020 Q1	$561K	Hold	22,500	–	–	0.16%	85
2019 Q4	$809K	Hold	22,500	–	–	0.22%	69
2019 Q3	$769K	Hold	22,500	–	–	0.25%	58
2019 Q2	$630K	Hold	22,500	–	–	0.21%	62
2019 Q1	$698K	Sell	22,500 -2,500	-10%	-$66.7K	0.24%	58
2018 Q4	$591K	Hold	25,000	–	–	0.22%	55
2018 Q3	$969K	Hold	25,000	–	–	0.29%	55
2018 Q2	$837K	Sell	25,000 -2,000	-7%	-$71.2K	0.23%	64
2018 Q1	$978K	Sell	27,000 -1,000	-4%	-$34.6K	0.28%	59
2017 Q4	$892K	Hold	28,000	–	–	0.24%	64
2017 Q3	$1.05M	Hold	28,000	–	–	0.27%	60
2017 Q2	$874K	Hold	28,000	–	–	0.23%	65
2017 Q1	$690K	Hold	28,000	–	–	0.18%	75
2016 Q4	$710K	Hold	28,000	–	–	0.18%	78
2016 Q3	$556K	Hold	28,000	–	–	0.15%	70
2016 Q2	$400K	Hold	28,000	–	–	0.11%	77
2016 Q1	$435K	Hold	28,000	–	–	0.11%	83
2015 Q4	$483K	Sell	28,000 -6,000	-18%	-$86.8K	0.12%	81
2015 Q3	$414K	Sell	34,000 -21,000	-38%	-$269K	0.1%	84
2015 Q2	$663K	Hold	55,000	–	–	0.14%	80
2015 Q1	$461K	Hold	55,000	–	–	0.1%	91
2014 Q4	$421K	Hold	55,000	–	–	0.09%	95
2014 Q3	$378K	Hold	55,000	–	–	0.08%	97
2014 Q2	$455K	Sell	55,000 -2,800	-5%	-$21.9K	0.09%	93
2014 Q1	$466K	Hold	57,800	–	–	0.1%	90
2013 Q4	$463K	Hold	57,800	–	–	0.1%	98
2013 Q3	$387K	Buy	57,800 +7,800	+16%	+$52.8K	0.09%	96
2013 Q2	$327K	Buy	+50,000	New	+$315K	0.08%	93

Other funds holding LMAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Needham Investment Management's LMAT Position: Q2 2026 in Review

Needham Investment Management held its LeMaitre Vascular (LMAT) position steady in Q2 2026 at 40,000 shares worth $3.84M. The position accounts for 0.12% of the portfolio, ranked #127.

Needham Investment Management first reported a position in LMAT in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.37M in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

Needham Investment Management held 40,000 shares of LeMaitre Vascular worth $3.84M as of Q2 2026.
Needham Investment Management left its LeMaitre Vascular share count unchanged in Q2 2026.
LeMaitre Vascular made up 0.12% of Needham Investment Management's portfolio in Q2 2026, its #127 holding.
Needham Investment Management first reported a position in LeMaitre Vascular in Q2 2013 and has held it in 53 quarters since.
Needham Investment Management's LeMaitre Vascular position peaked at $4.37M in Q1 2026.
326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Needham Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.